AHK 50mg Research Peptide
AHK 50mg is a laboratory research presentation containing 50mg of the tripeptide AHK, a short peptide sequence composed of alanine, histidine and lysine. AHK has attracted scientific interest because of its copper-binding characteristics and its use in controlled studies involving cellular signalling, dermal papilla cells and hair-follicle biology.
This vial-based presentation is intended for qualified researchers, analytical laboratories and scientific organisations requiring a clearly identified AHK research product. It is supplied exclusively for controlled laboratory analysis and is not intended for human or veterinary use.
Researchers exploring additional products from Apex Pharma can also view Reta 20mg, Reta Pen 20mg and Reta Pen 40mg. These products contain investigational retatrutide and belong to a separate area of peptide research.
AHK 50mg Product Overview
AHK 50mg provides researchers with a concentrated quantity of AHK in a sealed research vial. The product may be suitable for laboratories carrying out peptide identification, analytical method development, comparative peptide studies and other legitimate scientific investigations.
AHK is a tripeptide formed from three amino acids:
- Alanine: a small, non-polar amino acid
- Histidine: an amino acid involved in metal-ion coordination
- Lysine: a positively charged amino acid found in many peptide sequences
When AHK is complexed with copper, it is commonly referred to as AHK-Cu. Researchers should review the product label and batch documentation to confirm whether the material supplied is the uncomplexed peptide or its copper-bound form.
- Contains 50mg of AHK research material
- Supplied in a sealed vial presentation
- Designed for controlled laboratory investigation
- Suitable for analytical and comparative research
- Clearly identified for inventory management
- Batch documentation available where applicable
- Not intended for human or veterinary use
What Is AHK?
AHK is a short synthetic tripeptide with the amino-acid sequence alanine-histidine-lysine. Its structure allows it to coordinate copper ions through the histidine-containing region of the molecule, creating the copper-peptide complex commonly known as AHK-Cu.
Scientific interest in AHK has focused primarily on laboratory models involving human hair follicles and dermal papilla cells. Dermal papilla cells are specialised cells located within the hair follicle and play an important role in regulating follicular development and growth-cycle signalling.
Published in-vitro research has examined how AHK-Cu interacts with cultured human hair follicles and dermal papilla cells. These findings remain limited to controlled experimental models and should not be interpreted as evidence of an approved cosmetic or therapeutic application.
AHK and Copper-Binding Peptide Research
Copper-binding peptides are studied because copper ions participate in numerous biochemical and cellular processes. A peptide can influence how a metal ion is transported, stabilised or presented within an experimental system, making copper-peptide complexes relevant to biochemical and cellular research.
AHK is structurally related to other copper-binding tripeptides, although each sequence should be considered separately. Small changes in amino-acid composition can affect molecular interactions, metal-binding behaviour and experimental observations.
Potential areas of controlled research involving AHK may include:
- Copper-ion coordination
- Peptide-metal complex formation
- Dermal papilla cell behaviour
- Hair-follicle culture models
- Cell proliferation pathways
- Apoptosis-related signalling
- Comparative copper-peptide analysis
- Peptide structure-activity relationships
These areas describe scientific research interests rather than proven benefits or approved uses. Experimental results may vary according to peptide purity, concentration, laboratory conditions, analytical methods and the biological model selected.
Why Choose the 50mg Vial Presentation?
The 50mg presentation may be appropriate for established laboratory programmes requiring a larger quantity of AHK research material. It may help reduce the need for multiple smaller units where the complete amount can be stored, documented and handled under suitable laboratory conditions.
A 50mg vial may support:
- Repeated analytical procedures
- Longer-term laboratory projects
- Comparative peptide investigations
- Method-development programmes
- Multiple controlled assay runs
- Institutional research inventories
- Batch-specific stability analysis
Researchers should estimate the quantity required before purchasing. Ordering more material than a project needs may result in extended storage, unnecessary inventory or disposal of unused research material.
AHK 50mg Product Details
| Product name | AHK 50mg |
|---|---|
| Peptide sequence | Alanine-Histidine-Lysine |
| Peptide length | Tripeptide |
| Total quantity | 50mg |
| Presentation | Research vial |
| Research category | Copper-binding and cellular peptide research |
| Intended purpose | Laboratory, analytical and scientific research only |
| Human use | Not permitted |
AHK 50mg and Other Apex Pharma Research Products
AHK and retatrutide represent different peptide research categories. AHK is a short tripeptide commonly investigated in copper-binding, cellular and follicular laboratory models. Retatrutide is a larger investigational peptide studied for activity across GLP-1, GIP and glucagon receptor pathways.
| Product | Research compound | Presentation | Total quantity |
|---|---|---|---|
| AHK 50mg | AHK | Research vial | 50mg |
| Reta 20mg | Retatrutide | Research vial | 20mg |
| Reta Pen 20mg | Retatrutide | Pre-mixed research pen | 20mg |
| Reta Pen 40mg | Retatrutide | Pre-mixed research pen | 40mg |
Researchers should select products according to the compound, presentation and quantity required by their approved laboratory project. Products from different peptide categories should not be treated as interchangeable.
Research Applications for AHK 50mg
AHK 50mg may be used in controlled laboratory projects designed to investigate the structure, behaviour and experimental characteristics of short copper-binding peptides.
Hair-Follicle Research Models
AHK-Cu has been examined using cultured human hair follicles. These experimental systems allow researchers to observe follicular responses under carefully controlled in-vitro conditions without assuming that the same findings will occur outside the laboratory.
Dermal Papilla Cell Studies
Research has also considered the interaction between AHK-Cu and human dermal papilla cells. Areas of investigation have included cellular proliferation and molecular pathways associated with programmed cell death.
Peptide Comparison Studies
AHK may be compared with other short peptides to investigate how differences in amino-acid sequence affect copper binding, cellular interactions and analytical characteristics.
Analytical Method Development
The product may support laboratories developing chromatographic, spectrometric or other validated analytical methods for identifying and characterising short peptide sequences.
Batch Testing and Product Documentation
Batch-specific documentation is important when purchasing research peptides. Analytical reports can help connect the supplied product with a particular manufacturing lot and provide information about the tests performed on a representative sample.
Depending on the available testing programme, documentation may include:
- Product identification
- Batch or lot number
- Date of analysis
- Chromatographic purity
- Molecular mass information
- Analytical methods used
- Physical appearance
- Testing-laboratory details
Researchers should ensure that the documentation relates specifically to AHK 50mg and the batch being purchased. A report for another peptide or an earlier production lot should not automatically be applied to the current product.
Storage and Laboratory Handling
AHK 50mg should be stored according to the instructions displayed on the product label and any accompanying batch documentation. The product should remain clearly identified and protected from unsuitable environmental conditions.
General laboratory considerations include:
- Following the stated storage temperature
- Keeping the vial sealed until required
- Protecting the material from moisture
- Avoiding unnecessary light exposure
- Preventing unsuitable temperature fluctuations
- Recording the batch and date received
- Restricting access to authorised personnel
- Maintaining accurate inventory records
Specific product instructions should always take priority over general information. Preparation, analysis and disposal should only be carried out through approved laboratory procedures.
Who Is AHK 50mg Intended For?
AHK 50mg is intended for suitably equipped researchers and organisations with the knowledge, facilities and procedures required to handle research peptides responsibly.
Potential purchasers may include:
- Analytical laboratories
- University research departments
- Biotechnology organisations
- Contract research laboratories
- Peptide-analysis specialists
- Scientific procurement teams
- Educational research facilities
The product is not intended for consumers seeking cosmetic, medical or personal-use products. It must only be purchased, stored and handled for legitimate research purposes.
Why Buy AHK 50mg from Apex Pharma?
Apex Pharma supplies clearly identified research peptides in vial and pre-mixed research presentations. AHK 50mg provides a practical quantity for laboratories conducting established analytical or cellular research programmes.
Researchers choosing Apex Pharma can benefit from:
- Clearly stated product quantities
- Secure vial packaging
- Batch documentation where available
- Independent analytical testing where applicable
- UK-based customer support
- Reliable nationwide delivery
- A growing range of research peptides
- Products supplied exclusively for research
The wider Apex Pharma range includes Reta 20mg, Reta Pen 20mg and Reta Pen 40mg. Researchers should review the individual product information and current batch documentation before ordering.
Frequently Asked Questions
What is AHK 50mg?
AHK 50mg is a vial-based research product containing 50mg of the alanine-histidine-lysine tripeptide. It is intended solely for controlled laboratory, analytical and scientific investigation.
Is AHK the same as AHK-Cu?
AHK refers to the alanine-histidine-lysine peptide sequence. AHK-Cu refers specifically to AHK complexed with a copper ion. Researchers should check the product label and Certificate of Analysis to confirm the supplied form.
What areas of research involve AHK?
AHK and AHK-Cu have been studied in laboratory models involving copper binding, human hair follicles, dermal papilla cells, cell proliferation and apoptosis-related signalling.
Is AHK 50mg supplied as a vial?
Yes. This product is supplied in a sealed research vial containing a stated total quantity of 50mg.
Is AHK related to retatrutide?
No. AHK and retatrutide are structurally different research peptides associated with different areas of scientific investigation.
Which other research products are available?
Apex Pharma also supplies Reta 20mg, Reta Pen 20mg and Reta Pen 40mg for controlled laboratory research.
Is AHK 50mg intended for human use?
No. AHK 50mg is not intended for human or veterinary use. It must not be consumed, administered, used therapeutically or incorporated into personal experimentation.


C. Jones –
Very pleased with the AHK 50mg. It arrived promptly, was securely packaged and clearly labelled. Professional service and a smooth ordering experience.